{
  "id": 125252,
  "name": "COMPRESSED GAS ASSOCIATION",
  "slug": "compressed-gas-association",
  "state": "VA",
  "description": "Non-profit trade association",
  "totalSpending": 1510000,
  "filings": 32,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 90000
    },
    {
      "year": 2019,
      "income": 120000
    },
    {
      "year": 2020,
      "income": 150000
    },
    {
      "year": 2021,
      "income": 90000
    },
    {
      "year": 2022,
      "income": 140000
    },
    {
      "year": 2023,
      "income": 270000
    },
    {
      "year": 2024,
      "income": 280000
    },
    {
      "year": 2025,
      "income": 370000
    }
  ],
  "firms": [
    "HOLLAND & KNIGHT LLP"
  ],
  "lobbyists": [
    "JIM DAVIS",
    "JOEL ROBERSON",
    "ETHAN JORGENSEN-EARP",
    "CHRISTOPHER ARMSTRONG",
    "SCOTT MASON",
    "DANIEL SENNOTT",
    "PARKER REYNOLDS",
    "TODD WOOTEN",
    "BETH VIOLA",
    "ISABEL LANE",
    "JOSHUA ODINTZ",
    "MOLLY BROUGHTON",
    "MISHA LEHRER",
    "PATRICK CHILDRESS"
  ],
  "issues": [
    "HCR",
    "FOO",
    "NAT",
    null,
    "MAN",
    "TRD"
  ],
  "sampleDescriptions": [
    "Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2019 Food and Drug Administration Appropriations.",
    "Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2019 Food and Drug Administration Appropriations (H.R. 5961, S.2976).",
    "Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2020 Food and Drug Administration Appropriations.",
    "Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2020 Food and Drug Administration Appropriations (H.R. 3164).",
    "Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2020 Food and Drug Administration Appropriations (H.R. 3164 & S.2522).",
    "Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2021 Food and Drug Administration Appropriations.",
    "Carbon Dioxide (CO2) gas supply for food applications.",
    "Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2021 Food and Drug Administration Appropriations (H.R. 7610).",
    "Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2021 appropriations to the Food and Drug Administration Appropriations in H.R. 133, the Consolidated Appropriations Act of FY 2021; impact of COVID-19 on compressed gas manufacturers; COVID-19 vaccine cold storage; national supply of carbon dioxide.",
    "Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2022 appropriations to the Food and Drug Administration Appropriations; impact of COVID-19 on compressed gas manufacturers; COVID-19 vaccine cold storage; national supply of carbon dioxide.",
    "Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2022 appropriations to the Food and Drug Administration Appropriations (H.R. 4356 and S. 2599); safeguarding employees of compressed gas manufacturers from COVID-19; supply chain issues related to medical gases essential to the treatment of COVID-19.",
    "Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2022 appropriations to the Food and Drug Administration Appropriations (H.R. 4356 and S. 2599); safeguarding employees of compressed gas manufacturers from COVID-19; supply chain issues related to medical gases essential to the treatment of COVID-19; OSHA emergency temporary standard on COVID vaccination or testing.",
    "Federal helium reserve safety and reliable supply of helium.",
    "Regulation of medical gas product manufacturing and cylinders; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2022 appropriations to the Food and Drug Administration Appropriations (H.R. 4356 and S. 2599); FY 2023 appropriations to the Food and Drug Administration; supply chain issues related to medical gases essential to the treatment of COVID-19.",
    "Regulation of medical gas product manufacturing and cylinders; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2023 appropriations to the Food and Drug Administration (H.R. 8239); supply chain issues related to medical gases essential to the treatment of COVID-19.",
    "Federal helium reserve safety and reliable supply of helium; sale of the Federal Helium Reserve.",
    "Regulation of medical gas product manufacturing and cylinders; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2023 appropriations to the Food and Drug Administration (H.R. 8239 / S. 4661); FDA proposed rulemaking on Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases; supply chain issues related to medical gases essential to the treatment of COVID-19 and carbon dioxide.",
    "Safe production and reliable supply of helium; sale of the Federal Helium Reserve; helium supply chain issues.",
    "Regulation of medical gas product manufacturing and cylinders; implementation of medical gas provisions in Public Law 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of medical gas provisions in Public Law 115-31, the Consolidated Appropriations Act of 2017; FY 2023 appropriations to the Food and Drug Administration in the Fiscal Year 2023 Consolidated Appropriations Act (Public Law 117-328); FDA proposed rulemaking on Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases; supply chain issues related to medical gases for the treatment of COVID-19.",
    "Safe production and reliable supply of helium; sale of the Federal Helium Reserve; helium supply chain issues; carbon dioxide supply chain issues."
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": 311,
  "trajectory": "exploding",
  "yearsActive": 8,
  "avgAnnualSpending": 188750,
  "peakYear": 2025,
  "lobbyistCount": 14,
  "firmCount": 1,
  "issueCount": 5,
  "industry": "energy"
}